Blombery P, de Jong D, Ferry J, Hsi E, Ondrejka S, Seymour J
Histopathology. 2024; 86(1):69-78.
PMID: 39403047
PMC: 11648355.
DOI: 10.1111/his.15323.
Langabeer S
Oncol Res. 2024; 32(9):1423-1427.
PMID: 39220131
PMC: 11361905.
DOI: 10.32604/or.2024.051218.
Vijayanarayanan A, Wang S, Garces S, Saluja K, Medeiros L, Thakral B
EJHaem. 2024; 5(1):266-268.
PMID: 38406543
PMC: 10887325.
DOI: 10.1002/jha2.836.
Maitre E, Macro M, Troussard X
J Cell Mol Med. 2023; 27(17):2626-2630.
PMID: 37530550
PMC: 10468650.
DOI: 10.1111/jcmm.17890.
Mendez-Hernandez A, Moturi K, Hanson V, Andritsos L
Curr Oncol Rep. 2023; 25(8):833-840.
PMID: 37097545
PMC: 10126561.
DOI: 10.1007/s11912-023-01419-z.
Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders.
Maitre E, Paillassa J, Troussard X
Front Oncol. 2023; 12:1068981.
PMID: 36620555
PMC: 9815161.
DOI: 10.3389/fonc.2022.1068981.
Genomic landscape of mature B-cell non-Hodgkin lymphomas - an appraisal from lymphomagenesis to drug resistance.
Panda D, Das N, Thakral D, Gupta R
J Egypt Natl Canc Inst. 2022; 34(1):52.
PMID: 36504392
DOI: 10.1186/s43046-022-00154-z.
Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients.
Maitre E, Tomowiak C, Lebecque B, Bijou F, Benabed K, Naguib D
Cancers (Basel). 2022; 14(8).
PMID: 35454811
PMC: 9028144.
DOI: 10.3390/cancers14081904.
The Genomics of Hairy Cell Leukaemia and Splenic Diffuse Red Pulp Lymphoma.
Oscier D, Stamatopoulos K, Mirandari A, Strefford J
Cancers (Basel). 2022; 14(3).
PMID: 35158965
PMC: 8833447.
DOI: 10.3390/cancers14030697.
KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders.
Vendramini E, Bomben R, Pozzo F, Bittolo T, Tissino E, Gattei V
Cancers (Basel). 2022; 14(3).
PMID: 35158933
PMC: 8833570.
DOI: 10.3390/cancers14030666.
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.
Broccoli A, Terragna C, Nanni L, Martello M, Armuzzi S, Agostinelli C
Hematol Oncol. 2021; 40(1):57-62.
PMID: 34653277
PMC: 9291464.
DOI: 10.1002/hon.2932.
MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age.
Chakraborty R, Abdel-Wahab O, Durham B
Cold Spring Harb Perspect Med. 2020; 11(5).
PMID: 32601132
PMC: 7770072.
DOI: 10.1101/cshperspect.a034892.
A -Negative Classic Hairy Cell Leukemia Patient with Long-Lasting Complete Remission after Rituximab and Pentostatin.
Gozzetti A, Sammartano V, Bacchiarri F, Raspadori D, Bocchia M
Turk J Haematol. 2020; 37(4):286-287.
PMID: 32539314
PMC: 7702641.
DOI: 10.4274/tjh.galenos.2020.2020.0204.
Concomitant BRAF Mutation in Hairy Cell Leukemia and Papillary Thyroid Cancer: Case Report.
Mohamed S, Helmi F, El-Akiki S, El Omri H, Nashwan A, Yassin M
Case Rep Oncol. 2020; 12(3):922-927.
PMID: 32110210
PMC: 7036560.
DOI: 10.1159/000504929.
BRAF in the cross-hairs.
Geyer M, Abdel-Wahab O, Tallman M
Expert Rev Hematol. 2019; 12(3):183-193.
PMID: 30782032
PMC: 6614740.
DOI: 10.1080/17474086.2019.1583553.
New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes.
Maitre E, Bertrand P, Maingonnat C, Viailly P, Wiber M, Naguib D
Oncotarget. 2018; 9(48):28866-28876.
PMID: 29989027
PMC: 6034755.
DOI: 10.18632/oncotarget.25601.
Recent advances in understanding and managing hairy cell leukemia.
Roider T, Falini B, Dietrich S
F1000Res. 2018; 7.
PMID: 29770206
PMC: 5931274.
DOI: 10.12688/f1000research.13265.1.
Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.
Troussard X, Cornet E
Am J Hematol. 2017; 92(12):1382-1390.
PMID: 29110361
PMC: 5698705.
DOI: 10.1002/ajh.24936.
Targeted/exome sequencing identified mutations in ten Chinese patients diagnosed with Noonan syndrome and related disorders.
Xu S, Fan Y, Sun Y, Wang L, Gu X, Yu Y
BMC Med Genomics. 2017; 10(1):62.
PMID: 29084544
PMC: 5663114.
DOI: 10.1186/s12920-017-0298-6.
Hairy Cell Lymphoma: A Potentially Under-Recognized Entity.
Hammond W, Swaika A, Menke D, Tun H
Rare Tumors. 2017; 9(1):6518.
PMID: 28458788
PMC: 5379228.
DOI: 10.4081/rt.2017.6518.